Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

Adem Yesuf Dawed, Kaixin Zhou, Ewan Robert Pearson  Division of Cardiovascular and Diabetes Medicine, Medical Research Institute, University of Dundee, Dundee, Scotland, UK Abstract: Type 2 diabetes is one of the leading causes of morbidity and mortality, consuming a significant p...

Full description

Bibliographic Details
Main Authors:	Dawed AY, Zhou K, Pearson ER
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-04-01
Series:	Pharmacogenomics and Personalized Medicine
Subjects:	pharmacogenetics type 2 diabetes oral hypoglycaemic agents pharmacokinetics pharmacodynamics response
Online Access:	https://www.dovepress.com/pharmacogenetics-in-type-2-diabetes-influence-on-response-to-oral-hypo-peer-reviewed-article-PGPM

Similar Items

Pharmacogenetics of hypoglycemic agents
by: Irina Vladimirovna Kononenko, et al.
Published: (2015-12-01)

Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal Cancer
by: Apostolos Papachristos, et al.
Published: (2020-05-01)

Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus
by: B. Siddhartha Kumar, et al.
Published: (2012-04-01)

Pharmacogenetics of carbamazepine
by: N. A. Shnayder, et al.
Published: (2020-01-01)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022-08-01)

Hypoglycemic agents and prognostic outcomes of chronic kidney disease patients with type 2 diabetes
by: Kyaw Kyaw Hoe, et al.
Published: (2023-06-01)

Factors influencing adherence towards oral hypoglycaemic agents- A cross-sectional study among patients with Type II Diabetes Mellitus
by: Abhilash P, et al.
Published: (2023-10-01)

Advances in the management of type 2 diabetes mellitus
by: Nariman Moustafa
Published: (2012-01-01)

Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19
by: Amrit K. Sandhu, et al.
Published: (2023-09-01)

Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey
by: Delia Bogdanet, et al.
Published: (2019-01-01)

Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility
by: Saldivar JS, et al.
Published: (2016-01-01)

Nanomedicine: pharmacological perspectives
by: Bhattacharya Santanu, et al.
Published: (2012-06-01)

A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trial
by: Sinem Karaterzi, et al.
Published: (2024-02-01)

Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
by: Bo-Yeon Kim, et al.
Published: (2011-06-01)

Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas
by: A Winkler, et al.
Published: (2002-07-01)

Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials
by: Cindy Hoi Ting Yeung, et al.
Published: (2024-01-01)

Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer
by: Jean-Marc Ferrero, et al.
Published: (2023-02-01)

Type 2 diabetes and cancer: problems and suggestions for best patient management
by: Agostino Milluzzo, et al.
Published: (2020-08-01)

Factors contributing to hypoglycemia among patient with diabetes presenting with symptomatic hypoglycemia to a tertiary care centre of northern Sri Lanka
by: Niranjini Perinpanathan, et al.
Published: (2018-08-01)

Pharmacokinetics and antibacterial activity of tiamulin after single and multiple oral administrations in geese
by: Irene Sartini, et al.
Published: (2023-12-01)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
by: Natalia A. Shnayder, et al.
Published: (2021-04-01)

Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia
by: Estela Sangüesa, et al.
Published: (2024-03-01)

Pharmacokinetic and drug absorption profiles of the anti-hyperglycaemic agent gliclazide in oral tissue-targeted microcapsules in rats
by: Jović Jelena, et al.
Published: (2020-01-01)

Pharmacogenetic aspects of oral hypoglycemic therapy. Response and failure phenotypes
by: Y. A. Sorokina
Published: (2015-12-01)

Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy
by: Paola Ballotari, et al.
Published: (2017-10-01)

Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid
by: Eric H. Decloedt, et al.
Published: (2021-04-01)

Pharmacogenetics in Primary Headache Disorders
by: Irina I. Belyaeva, et al.
Published: (2022-02-01)

Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
by: Rambiritch V, et al.
Published: (2016-09-01)

Knowledge of patients with type 2 diabetes mellitus about their condition - a descriptive analysis
by: M. K. Wijesinghe, et al.
Published: (2016-02-01)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults
by: Bakouni H, et al.
Published: (2019-05-01)

Is REmogliflozin an effective Drug in MANaging Type-2 diabetes mellitus: A comparative study – (REDMAN)
by: Prabhat Agrawal, et al.
Published: (2022-07-01)

Type 2 diabetes mellitus: Clinical aspects of genetics, nutrigenetics, and pharmacogenetics
by: A S Ametov, et al.
Published: (2015-08-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

Analysis of the regional pharmaceutical market of hypoglycemic drugs of oral administration
by: Orlova T.S., et al.
Published: (2017-06-01)

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)

A-type procyanidins from litchi pericarp ameliorate hyperglycaemia by regulating hepatic and muscle glucose metabolism in streptozotocin (STZ)-induced diabetic mice fed with high fat diet
by: Xiaopeng Li, et al.
Published: (2016-12-01)

Hypoglycaemic effect of alcoholic extract of olive (Olea europaea L.) leaf in healthy and diabetic rats
by: A Eidi, et al.
Published: (2004-11-01)

Pharmacogenetics of new classes of antidiabetic drugs
by: Selma Imamovic Kadric, et al.
Published: (2021-12-01)

Linezolid Resistant Enterococcus: An Important Emerging Pathogen Isolated from a Non Healing Ulcer of a Diabetic Foot Patient
by: Priya Datta, et al.
Published: (2017-12-01)

Role of Pharmacogenomics in Statin Responsiveness; A Review
by: Niusha behdad, et al.
Published: (2015-12-01)